View this message in your internet browser.

How Will Screening and Shifts within MI Procedures Drive the Global Breast Biopsy Device Market?

—A Complimentary Webinar from Millennium Research Group

Breast cancer screening programs are helping drive global breast biopsy device markets. As a greater number of suspicious lesions are identified through screening, the number of lesions that require a biopsy to determine malignancy increases.

In addition, clinicians are shifting away from open surgical breast biopsy procedures and toward minimally invasive procedures such as vacuum-assisted biopsy, core needle biopsy or fine needle aspiration. Within the various types of minimally invasive procedures, different geographic regions are showing differing preferences based on availability, diagnostic accuracy and culture.

Please join us for an in-depth analysis of this market within the context of our new report:

Global Markets for Breast Biopsy Devices 2013

Request more information about this webinar.

Our Analyst, Michelle Chan, will cover the following topics:

  • What are the breast biopsy device market trends in each country? How will preference for certain types of procedures shift into 2017?
  • What are the current trends for image-guided breast biopsy? How will these advanced imaging systems affect the breast biopsy market?
  • How are the trends in the global breast screening market affecting the breast biopsy device market?
  • How does each type of breast biopsy device compare to the other? Why are clinicians choosing one type of device over the other?

Register now!

How Will Screening and Shifts within MI Procedures Drive the Global Breast Biopsy Device Market?

Register for MRG’s COMPLIMENTARY webinar.

The webinar will take place on February 12, 2013 at 11:00 am US Eastern Time, 8 am US Pacific Time, 5 pm Central European Time (Paris).

Contact us

Aline Nouh | +1 (416) 364-7776 x392 |

Millennium Research Group

Register now!

Webinar Details

Date & Time
Tuesday, February 12, 2013
11 a.m. EST

Duration: 25 minutes

About the Speaker

Michelle Chan is an Analyst at MRG’s diagnostic imaging and health care information technology division where she is the author of the Global Markets for Breast Biopsy Devices 2013 report. Additionally, Michelle has worked on the women’s health imaging market in Europe and the diagnostic imaging market in China. Michelle holds a Bachelor in Science in Engineering, specializing in biochemical engineering from Queen’s University.

Decision Resources

Terms of Use | Privacy Policy | Contact Us | Careers

Millennium Research Group • 175 Bloor Street East, South Tower Suite 400 • Toronto, CANADA M4W 3R8

© Millennium Research Group, Inc. All rights reserved.

Follow us on Twitter Join our group on LinkedIn Subscribe to our RSS feeds Hear Conference Commentary Podcasts Visit our blog!